Related Research Articles
Leptin also obese protein is a protein hormone predominantly made by adipocytes. Its primary role is likely to regulate long-term energy balance.
Adipose tissue is a loose connective tissue composed mostly of adipocytes. It also contains the stromal vascular fraction (SVF) of cells including preadipocytes, fibroblasts, vascular endothelial cells and a variety of immune cells such as adipose tissue macrophages. Its main role is to store energy in the form of lipids, although it also cushions and insulates the body.
Resistin also known as adipose tissue-specific secretory factor (ADSF) or C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein (XCP1) is a cysteine-rich peptide hormone derived from adipose tissue that in humans is encoded by the RETN gene.
The Pennington Biomedical Research Center is a health science-focused research center in Baton Rouge, Louisiana. It is part of the Louisiana State University System and conducts clinical, basic, and population science research. It is the largest academically-based nutrition research center in the world, with the greatest number of obesity researchers on faculty. The center's over 500 employees occupy several buildings on the 222-acre (0.90 km2) campus. The center was designed by the Baton Rouge architect John Desmond.
Adipose tissue is an endocrine organ that secretes numerous protein hormones, including leptin, adiponectin, and resistin. These hormones generally influence energy metabolism, which is of great interest to the understanding and treatment of type 2 diabetes and obesity.
Daniel Willett Foster was the John Denis McGarry, Ph.D. Distinguished Chair in Diabetes and Metabolic Research and Professor of Internal Medicine at the University of Texas Southwestern Medical School at Dallas. He was Chairman of the Department of Internal Medicine for 16 years. He was a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science and a member of the Institute of Medicine of the National Academies. He was a Master of the American College of Physicians. He was also a former member of the President's Council on Bioethics.
Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).
JeffreyFlier is an American physician, endocrinologist; widely cited scientist; the Higginson Professor of Medicine and Physiology at Harvard Medical School; and a Distinguished Service Professor at the same institution. He was the 21st Dean of the Faculty of Medicine at Harvard University from 2007 to 2016.
Bernhard Ludvik is a Specialist in Internal Medicine, board certified in Endocrinology and Metabolism. He is currently an Associate Professor of Medicine at the Medical University of Vienna. He serves as the Deputy Head of the Division of Endocrinology and Metabolism at the General Hospital Vienna.
Mitchell Lazar is an endocrinologist and physician-scientist known for his discovery of the hormone resistin and his contributions to the transcriptional regulation of metabolism.
Michael Warren Schwartz is Robert H. Williams Endowed Chair, Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington and Director of the UW Medicine Diabetes and Obesity Center of Excellence. He is the Director of the NIH-funded Nutrition Obesity Research Center (NORC) at the University of Washington. His research investigates brain mechanisms governing energy balance and glucose metabolism and how obesity and diabetes result from impairment of these brain systems. He has published more than 200 articles and book chapters related to these topics and his research has been continuously funded by the NIH since joining the faculty of UW 18 years ago. Dr. Schwartz is a member of the Association of American Physicians, the Western Association of Physicians, and the American Society for Clinical Investigation, is the recipient of the 2007 Williams-Rachmiel Levine Award for Outstanding Mentorship from the Western Society for Clinical Investigation, the 2006 Naomi Berrie Award for Outstanding Achievement in Diabetes Research from Columbia University, and was the 2012 Solomon A. Berson Lecturer for the American Physiological Society, among other awards. He is a member of the editorial boards of the Journal of Clinical Investigation, American Journal of Physiology, Endocrine Reviews, Molecular Metabolism and Frontiers in Neuroendocrinology.
Sir Stephen Patrick O'Rahilly is an Irish-British physician and scientist known for his research into the molecular pathogenesis of human obesity, insulin resistance and related metabolic and endocrine disorders.
Rudolph Leibel is the Christopher J. Murphy Professor of Diabetes Research, Professor of Pediatrics and Medicine at Columbia University Medical Center, and Director of the Division of Molecular Genetics in the Department of Pediatrics. He is also co-director of the Naomi Berrie Diabetes Center and executive director of the Russell and Angelica Berrie Program in Cellular Therapy, Co-director of the New York Obesity Research Center and the Columbia University Diabetes and Endocrinology Research Center.
José F. Caro is an American physician, scientist, and educator most notable for his research in obesity and diabetes. The Institute for Scientific Information listed him the third most cited investigator in the world in the field of obesity research during the 1991-2000 period for his work on Leptin. Caro is an artist and a signature member of the Pastel Society of America.
Matthias H. Tschöp is a German physician and scientist. He is the chief executive officer and scientific director of Helmholtz Zentrum München, German Research Center for Environmental Health. He is also Alexander von Humboldt Professor and chair of metabolic diseases at Technical University of Munich and serves as an adjunct professor at Yale University.
Christos Socrates Mantzoros is a Greek American physician-scientist, practicing internist-endocrinologist, teacher and researcher. He is a professor of medicine at Harvard Medical School and an adjunct professor at Boston University School of Medicine. He currently serves as the chief of endocrinology, diabetes and metabolism at the VA Boston Healthcare System, where he created de novo a leading academic division true to its tripartite mission and as the founding director of human nutrition at Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School. Finally, he holds the editor-in-chief position of the journal Metabolism: Clinical and Experimental.
Malcolm Daniel Lane was a biochemist who spent most of his career on the faculty at the Johns Hopkins School of Medicine in Baltimore, Maryland. Lane served as the head of the Department of Biological Chemistry from 1978 to 1997, was elected to the National Academy of Sciences in 1987, and was named a University Distinguished Service Professor – the institution's highest academic title – in 2001. Lane's research focused on the biochemistry of lipids and lipid metabolism, and the resulting physiological mechanisms regulating adipogenesis and obesity.
Paul Michael Stewart FMedSci FRCP is Dean of Medicine and Health at the University of Leeds and an Honorary Consultant Endocrinologist at the Leeds Teaching Hospitals NHS Trust. He is also currently Vice President of the Academy of Medical Sciences and the editor-in-chief of The Journal of Clinical Endocrinology and Metabolism.
Antonio Vidal-Puig is a Spanish medical doctor and scientist who works as a Professor of Molecular Nutrition and Metabolism at the University of Cambridge (UK), best known for advancing the concept that pharmacological targeting of brown fat may serve to treat overweight and obesity in affected individuals, as well as for introducing the concept of adipose tissue "expandability" as an important factor in the pathogenesis of insulin resistance in the context of positive energy balance. His published work focuses on areas such as adipose tissue metabolism and lipotoxicity, regulation of insulin secretion, and the pathophysiology of metabolic syndrome, obesity, and type 2 diabetes.
Eleftheria Maratos-Flier is an American endocrinologist, and emerita Professor of Medicine at Harvard Medical School, best known for her expertise in the pathophysiology and prevention of obesity-related metabolic disorders, and for her discoveries on the neuroendocrine control of feeding behaviour. She is a contributing author to known textbooks and reviews in internal medicine, endocrinology, and physiology. Her marriage with professor Jeffrey Flier, was noted by Forbes as a lasting and productive bond between eminent medical scholars. They have two adult daughters who are also physicians. She is also known as Terry Maratos-Flier.
References
- ↑ Gisela Crespo. "Warming temperatures could mean more heat-related illnesses and new diseases, experts warn". CNN. Retrieved 2021-03-02.
- ↑ "Rexford S. Ahima". Johns Hopkins University School of Medicine.
- 1 2 Messersmith, Julie. "Rexford Ahima named Bloomberg Distinguished Professor at Johns Hopkins", JHU Hub, Baltimore, 23 February 2016. Retrieved on 23 February 2016.
- ↑ Wasta, Vanessa (2020-10-19). "Four from Johns Hopkins Medicine elected to the National Academy of Medicine". The Hub. Retrieved 2020-10-19.
- ↑ "National Academy of Medicine elects 100 new members". EurekAlert!. Retrieved 2021-03-02.
- 1 2 "Rexford S. Ahima elected as JCI Editor in Chief". The American Society for Clinical Investigation. Retrieved 13 June 2019.
- ↑ Ahima, Rexford S. (2022-02-01). "Ayekoo! — Well done!". The Journal of Clinical Investigation. 132 (3). doi:10.1172/JCI158278. ISSN 0021-9738. PMC 8803334 . PMID 35104809.
- ↑ "Rexford S. Ahima - Faculty Directory". Johns Hopkins Bloomberg School of Public Health. Retrieved 2021-01-21.
- ↑ Murphy, Anar (2018-03-26). "Ann NY Acad Sci Special Issue The Year in Diabetes and Obesity". Advanced Science News. Retrieved 2021-03-02.
- ↑ "Rexford Ahima". scholar.google.com. Retrieved 2021-05-11.
- ↑ "Can the Obesity Crisis Be Reversed? | Johns Hopkins University Press Books". jhupbooks.press.jhu.edu. Retrieved 2021-05-11.
